News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
375,829 Results
Type
Article (25736)
Company Profile (70)
Press Release (350023)
Section
Business (104195)
Career Advice (450)
Deals (16863)
Drug Delivery (47)
Drug Development (47518)
Employer Resources (50)
FDA (12228)
Job Trends (8420)
News (185742)
Policy (19388)
Tag
Academia (1732)
Alliances (26599)
Alzheimer's disease (736)
Approvals (12227)
Artificial intelligence (99)
Bankruptcy (136)
Best Places to Work (6864)
Breast cancer (131)
Cancer (885)
Cardiovascular disease (78)
Career advice (411)
Cell therapy (142)
Clinical research (39667)
Collaboration (266)
Compensation (63)
COVID-19 (1457)
C-suite (64)
Data (955)
Diabetes (110)
Diagnostics (3384)
Earnings (36060)
Events (50734)
Executive appointments (249)
FDA (12770)
Funding (229)
Gene therapy (77)
GLP-1 (330)
Government (2997)
Healthcare (12144)
Infectious disease (1508)
Inflammatory bowel disease (67)
IPO (6985)
Job creations (1837)
Job search strategy (379)
Layoffs (153)
Legal (3617)
Lung cancer (147)
Lymphoma (63)
Manufacturing (75)
Medical device (12738)
Medtech (12741)
Mergers & acquisitions (9994)
Metabolic disorders (289)
Neuroscience (932)
NextGen Class of 2024 (3928)
Non-profit (2816)
Northern California (875)
Obesity (166)
Opinion (63)
Parkinson's disease (59)
Patents (62)
People (34211)
Phase I (11352)
Phase II (17180)
Phase III (14104)
Pipeline (291)
Postmarket research (1667)
Preclinical (3541)
Radiopharmaceuticals (156)
Rare diseases (123)
Real estate (2838)
Regulatory (13784)
Research institute (1598)
Southern California (760)
Startups (2117)
United States (8515)
Vaccines (297)
Weight loss (115)
Date
Today (76)
Last 7 days (334)
Last 30 days (1376)
Last 365 days (19876)
2024 (19794)
2023 (22743)
2022 (30683)
2021 (32990)
2020 (32202)
2019 (28420)
2018 (21813)
2017 (18913)
2016 (18114)
2015 (21197)
2014 (16031)
2013 (13243)
2012 (14352)
2011 (14625)
2010 (13182)
Location
Africa (354)
Arizona (93)
Asia (24152)
Australia (3819)
California (1939)
Canada (879)
China (216)
Colorado (109)
Connecticut (114)
Delaware (66)
Europe (47102)
Florida (330)
Georgia (85)
Illinois (263)
Indiana (158)
Japan (56)
Kansas (67)
Maryland (461)
Massachusetts (1410)
Michigan (77)
Minnesota (195)
New Jersey (715)
New York (601)
North Carolina (423)
Northern California (875)
Ohio (92)
Pennsylvania (574)
South America (519)
Southern California (760)
Texas (331)
Utah (63)
Washington State (161)
375,829 Results for "attune medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Haemonetics Corporation Completes Acquisition of Attune Medical
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has completed its previously announced acquisition of privately-held Chicago-based Attune Medical, the manufacturer of the ensoETM® proactive esophageal cooling device.
April 1, 2024
·
7 min read
Deals
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Haemonetics Corporation announced that it has entered into a definitive agreement to acquire privately-held Chicago-based Attune Medical, the manufacturer of the ensoETM® proactive esophageal cooling device, the only FDA-cleared temperature regulation device indicated for esophageal protection during radiofrequency cardiac ablation procedures.
March 5, 2024
·
6 min read
BioMidwest
Attune Medical® Announces Support of AF Symposium 2024
Attune Medical®, a pioneer in the field of esophageal temperature management with its ensoETM® device, is providing significant support for the upcoming AF Symposium as part of the company’s corporate mission.
January 17, 2024
·
4 min read
Press Releases
Bionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM Evidence
December 9, 2024
·
5 min read
BioMidwest
Rapid Growth at Attune Medical Spurs Strategic Hires and Expansion
Attune Medical, a pioneer in utilizing the esophageal space to proactively manage patient temperature and to reduce the likelihood of esophageal injury during cardiac ablation procedures, announces significant growth with three key additions and expansion of commercial operations.
December 14, 2023
·
4 min read
Drug Development
Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder
Bionomics Limited announced the release of the full dataset analysis from its Phase 2b ATTUNE trial in patients with post-traumatic stress disorder.
March 21, 2024
·
10 min read
BioCapital
MCRA Assists Attune Medical on FDA De Novo Marketing Authorization for ensoETM™ Esophageal Thermal Regulating Device
MCRA, LLC is pleased to announce its role in assisting Attune Medical with its De Novo marketing authorization from the US Food and Drug Administration (FDA) for the ensoETM™ device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
October 11, 2023
·
5 min read
BioMidwest
Attune Medical’s ensoETM™ Granted FDA De Novo Marketing Authorization to Reduce the Likelihood of Ablation-related Esophageal Injury Resulting from Radiofrequency Cardiac Ablation Procedures
Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.
September 14, 2023
·
4 min read
Business
Attune Medical and Heart Rhythm Clinical Research Solutions (HRCRS) Collaborate with Real World Evidence Consortium Members to Evaluate ensoETM™ in High Volume Centers
Attune Medical and Heart Rhythm Clinical Research Solutions (HRCRS) are partnering on an evaluation of Attune’s ensoETM thermal regulating device through the HRCRS Real World Evidence (RWE) consortium.
April 11, 2023
·
3 min read
BioMidwest
Heart Rhythm Clinical and Research Solutions and the Real World Evidence Consortium Launch EVERCOOL AF Study on Attune Medical’s ensoETM®
Heart Rhythm Clinical and Research Solutions and the Real World Evidence Consortium have enrolled the first patient in the REView of ProcEdural FactoRs and Outcomes after Atrial Fibrillation Ablation with Active Esophageal COOLing study.
April 4, 2024
·
4 min read
1 of 37,583
Next